Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127878591 | 12787859 | 1 | I | 20160920 | 20160928 | 20160928 | PER | US-EISAI MEDICAL RESEARCH-EC-2016-020578 | EISAI | 0.00 | M | Y | 76.40000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127878591 | 12787859 | 1 | PS | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | Oral | 20690 | 5 | MG | TABLET | QD | |||||||
| 127878591 | 12787859 | 2 | SS | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | Oral | 20690 | 10 | MG | TABLET | QD | |||||||
| 127878591 | 12787859 | 3 | SS | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | Oral | 20690 | 5 | MG | TABLET | QD | |||||||
| 127878591 | 12787859 | 4 | C | WARFARIN | WARFARIN | 1 | UNKNOWN | 0 | |||||||||||
| 127878591 | 12787859 | 5 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | UNKNOWN | 0 | |||||||||||
| 127878591 | 12787859 | 6 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 0 | 10 | MG | ||||||||||
| 127878591 | 12787859 | 7 | C | CARBIDOPA/LEVODOPA | CARBIDOPALEVODOPA | 1 | 0 | 100 | MG | ||||||||||
| 127878591 | 12787859 | 8 | C | MYRBETRIQ | MIRABEGRON | 1 | 0 | 25 | MG | ||||||||||
| 127878591 | 12787859 | 9 | C | MYRBETRIQ | MIRABEGRON | 1 | 0 | 50 | MG | ||||||||||
| 127878591 | 12787859 | 10 | C | BABY ASPIRIN | ASPIRIN | 1 | 0 | 81 | MG | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127878591 | 12787859 | 1 | Product used for unknown indication |
| 127878591 | 12787859 | 4 | Thrombosis prophylaxis |
| 127878591 | 12787859 | 5 | Product used for unknown indication |
| 127878591 | 12787859 | 7 | Product used for unknown indication |
| 127878591 | 12787859 | 8 | Product used for unknown indication |
| 127878591 | 12787859 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127878591 | 12787859 | Gait disturbance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127878591 | 12787859 | 5 | 20160829 | 0 | ||
| 127878591 | 12787859 | 6 | 20160830 | 0 |